Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity
-
Published:2024-08
Issue:2
Volume:154
Page:435-446
-
ISSN:0091-6749
-
Container-title:Journal of Allergy and Clinical Immunology
-
language:en
-
Short-container-title:Journal of Allergy and Clinical Immunology
Author:
Runnstrom Martin C., Lamothe Pedro A.ORCID, Faliti Caterina E., Cheedarla Narayanaiah, Moreno Alberto, Suthar Mehul S., Nahata Rishika, Ravindran Mayuran, Haddad Natalie S., Morrison-Porter Andrea, Quehl Hannah, Ramonell Richard P., Woodruff Matthew, Anam Fabliha, Zhang Rebeca, Swenson Colin, Polito Carmen, Neveu Wendy, Patel Rahulkumar, Smirnova Natalia, Nguyen Doan C., Kim Caroline, Hentenaar Ian, Kyu Shuya, Usman Sabeena, Ngo Thuy, Guo Zhenxing, Wu Hao, Daiss John L., Park Jiwon, Manning Kelly E., Wali Bursha, Ellis Madison L., Sharma Sunita, Holguin Fernando, Cheedarla Suneethamma, Neish Andrew S., Roback John D., Sanz Ignacio, Eun-Hyung Lee F.ORCID
Funder
National Institutes of Health
|
|